Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.117ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.117ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.117EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.117EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.117ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.117ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.381EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.381ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.381EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.381EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.381ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.237EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.237ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.237EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.237EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.237ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.237ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.382EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.382ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.382EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.382EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.382ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.395EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.395ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.395EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.395EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.395ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.74ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.53EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.53ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.53ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used